AIC
WST icon

Aurora Investment Counsel’s West Pharmaceutical WST Stock Holding History

Aurora Investment Counsel’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,715
Closed -$1.02M – 125
2023
Q3 		$1.02M Sell
2,715
-387
-12% -$150K 0.67% 88
2023
Q2 		$1.19M Sell
3,102
-2,429
-44% -$868K 0.76% 74
2023
Q1 		$1.92M Sell
5,531
-117
-2% -$34.2K 1.25% 15
2022
Q4 		$1.33M Buy
+5,648
New +$1.34M 0.92% 54
2020
Q2 		– Sell
-6,883
Closed -$1.05M – 132
2020
Q1 		$1.05M Sell
6,883
-925
-12% -$142K 1.16% 23
2019
Q4 		$1.17M Sell
7,808
-3,169
-29% -$461K 0.88% 59
2019
Q3 		$1.56M Buy
+10,977
New +$1.51M 0.76% 77

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Aurora Investment Counsel's WST Position: Q4 2023 in Review

Aurora Investment Counsel sold out of West Pharmaceutical (WST) in Q4 2023, closing a stake of 2,715 shares — an estimated $1.02M sold.

Aurora Investment Counsel first reported a position in WST in Q3 2019 and held it in 7 quarters. The position peaked at $1.92M in Q1 2023. 783 funds tracked by Wall St. Rank hold WST as of Q4 2023.

  • Aurora Investment Counsel reported no remaining West Pharmaceutical position as of Q4 2023 after selling out during the quarter.
  • Aurora Investment Counsel sold 2,715 West Pharmaceutical shares in Q4 2023, an estimated $1.02M.
  • Aurora Investment Counsel first reported a position in West Pharmaceutical in Q3 2019 and held it in 7 quarters.
  • Aurora Investment Counsel's West Pharmaceutical position peaked at $1.92M in Q1 2023.
  • 783 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2023.

Based on Aurora Investment Counsel's 13F filing for Q4 2023, filed 20 Feb 2024.